Skip to main content
HHS Author Manuscripts logoLink to HHS Author Manuscripts
. Author manuscript; available in PMC: 2024 Sep 4.
Published in final edited form as: Birth Defects Res. 2024 Aug;116(8):e2390. doi: 10.1002/bdr2.2390

Folate and Vitamin B12 Status in Women of Reproductive Age in Rural Haryana, India: Estimating Population-Based Prevalence for Neural Tube Defects

Reena Das 1, Mona Duggal 2, Jorge Rosenthal 3, Ankita Kankaria 4, Hari K Senee 1, Shameem Jabbar 5, Manmeet Kaur 4, Vishal Kumar 6, Swati Bhardwaj 7, Neha Singh 4, Gursharan S Dhanjal 4, Akash Kumar 4, Charles E Rose 3, Rita Bhatia 8, Rachita Gupta 9, Suresh Dalpath 10, Krista S Crider 3, Mindy Zhang 5, Christine M Pfeiffer 5, Rakesh Gupta 11, Rajesh Mehta 12, Neena Raina 12, Lorraine F Yeung 3
PMCID: PMC11373839  NIHMSID: NIHMS2017960  PMID: 39162364

Abstract

Background:

Folate and vitamin B12 deficiencies in pregnant women are associated with increased risk for adverse maternal and infant health outcomes, including neural tube defects (NTDs).

Methods:

A population-based cross-sectional survey was conducted in two rural areas in Ambala District, Haryana, India in 2017 to assess baseline folate and vitamin B12 status among women of reproductive age (WRA) and predict the prevalence of NTDs. We calculated the prevalence of folate and vitamin B12 deficiency and insufficiency by demographic characteristics among 775 non-pregnant, non-lactating WRA (18–49 years). Using red blood cell (RBC) folate distributions and an established Bayesian model, we predicted NTD prevalence. All analyses were conducted using SAS-callable SUDAAN Version 11.0.4 to account for complex survey design.

Results:

Among WRA, 10.1% (95% CI: 7.9, 12.7) and 9.3% (95% CI: 7.4, 11.6) had serum (<7 nmol/L) and RBC folate (<305 nmol/L) deficiency, respectively. The prevalence of RBC folate insufficiency (<748 nmol/L) was 78.3% (95% CI: 75.0, 81.3) and the predicted NTD prevalence was 21.0 (95% uncertainly interval: 16.9, 25.9) per 10,000 live births. Prevalences of vitamin B12 deficiency (<200 pg/mL) and marginal deficiency (≥200 pg/mL and ≤300 pg/mL) were 57.7% (95% CI: 53.9, 61.4) and 23.5% (95% CI: 20.4, 26.9), respectively.

Conclusions:

The magnitude of folate insufficiency and vitamin B12 deficiency in this Northern Indian population is a substantial public health concern. The findings from the survey help establish the baseline against which results from future post-fortification surveys can be compared.

Keywords: India, neural tube defects, red blood cell folate, serum folate, serum vitamin B12, women of reproductive age

1 |. Introduction

Folate and vitamin B12 deficiencies in pregnant women are associated with increased risk for adverse maternal and infant health outcomes, including neural tube defects (NTDs) (World Health Organization 2015a, 2015b; Finkelstein, Layden, and Stover 2015; Bailey and Hausman 2018; Ray et al. 2007; Molloy et al. 2008, 2009; Molloy 2018). Neural tube defects are severe birth defects of the brain and spine due to failure of neural tube closure by the 28th day of conception and can lead to fetal and infant deaths, as well as lifelong disabilities (Cordero et al. 2015; Centers for Disease Control and Prevention 1992; Crider et al. 2022).

It is estimated that over 260,000 infants with NTDs are born every year globally (prevalence: 18.6 per 10,000 live births), with higher prevalence in low and middle-income countries (Blencowe et al. 2018; Zaganjor et al. 2016; Lo, Polšek, and Sidhu 2014; Atta et al. 2016). The prevalence of NTDs in India, estimated to be 41–45 per 10,000 births, is among the highest globally, with wide variations across the country ranging from 5 per 10,000 births in Maharashtra to 182 per 10,000 births in Haryana (Bhide et al. 2013; Allagh et al. 2015; Sharma and Gulati 1992; Taksande et al. 2010).

Since NTDs occur in the early weeks of pregnancy, often before women know they are pregnant, it is important that women have adequate folate levels periconceptionally. Evidence has shown that the use of folic acid supplements during the periconceptional period can decrease the risk for NTDs (Smithells, Sheppard, and Schorah 1976; MRC Vitamin Study Research Group 1991; Czeizel and Dudás 1992; Berry et al. 1999). Multiple countries have been able to increase consumption of folate among women of reproductive age (WRA) through folic acid fortification of centrally produced staples (e.g., wheat flour); studies from these countries showed a substantial reduction (31%–78%) in the prevalence of NTDs post-fortification (Das et al. 2013; Cordero, Do, and Berry 2008; López-Camelo et al. 2005; Sayed et al. 2008; Calvo and Biglieri 2008; Williams et al. 2002; Liu et al. 2004; Persad et al. 2002; De Wals et al. 2003; Ray et al. 2002). Several meta-analyses of pre- and post-fortification prevalence of NTDs among different countries showed consistent results, a 41%–46% reduction in prevalence depending on the fortification dosage, intake, and baseline NTD prevalence (Blencowe et al. 2010; Keats et al. 2019; Crider et al. 2022). While micronutrient food fortification can be a successful public health approach to address micronutrient deficiencies, India currently does not have a national policy on fortification of centrally distributed staples with folic acid, vitamin B12, or iron. Micronutrient supplementation (e.g., iron and/or folic acid) has had limited success since the prevalence of micronutrient deficiencies, especially anemia (prevalence: 57% in women aged 15–49 years), remains high (Ministry of Health & Family Welfare, Government of India 2022). In Haryana, there is a high prevalence of anemia, folate deficiency, and vitamin B12 deficiency. The National Family Health Survey (NFHS-5) 2019–21 found that almost 61% of non-pregnant women aged 15–49 years in Haryana were anemic while another study found that 72% of adolescent girls in rural Haryana had anemia (Ministry of Health & Family Welfare, Government of India 2022; Subramanian et al. 2022). A study in one of the districts in Haryana found that 37% of the study participants (males and females aged 30–65 years) were folate deficient, and 46% of the participants were vitamin B12 deficient (Yadav, Thakur, and Kiranmala 2018).

Since the World Health Organization (WHO)’s establishment of the population-level red blood cell (RBC) folate threshold for the optimal prevention of NTDs among WRA in 2015, several countries were able to apply the WHO guidelines to population-based data to assess the prevalence of RBC folate insufficiency and predict NTD prevalence (World Health Organization 2015a; Cordero et al. 2015; Crider et al. 2014, 2018; Tinker et al. 2015; Rosenthal et al. 2016; Finkelstein et al. 2021). We use the same methodology to predict NTD prevalence in this study.

To address micronutrient deficiencies, multi-sector partners representing public, private, academic, and civic sectors collaborated beginning in 2017 on a large-scale wheat flour fortification demonstration project through social safety net programs in Haryana, India. The objectives of this study were to conduct a population-based household and biomarker survey in rural Ambala District, Haryana to assess the baseline folate and vitamin B12 status in WRA, as part of the fortification demonstration project and to predict NTD prevalence. Findings from this survey will serve as a baseline for future comparisons.

2 |. Methods

2.1 |. Ambala District and Population

Ambala District is one of 22 districts in Haryana, located in the northeastern part of the state. According to the 2011 Census, Ambala District had a population of 1,128,350 with 46.9% women, 84.7% Hindus, 2% Muslims, and 12.3% Sikhs. About 56% of the population lived in rural areas (Population Census 2011, 2011).

2.2 |. Study Design and Sample Selection

A population-based cross-sectional survey was conducted among non-institutionalized, non-pregnant women of reproductive age (18–49 years) in two rural blocks (sub-districts)—Naraingarh and Barara in Ambala District in 2017. To select a representative probability sample of households, a multi-stage probability proportional to size (PPS) sampling was used (Henderson and Sundaresan 1982). In the first stage of sampling, 52 villages were selected using PPS based on the sampling plan of 55 clusters. In the second stage, enumeration blocks (EB) in each of the selected villages were selected randomly. One EB was chosen from each of the 52 selected villages, except for three villages from which two EBs were selected. A total of 55 EBs were selected in the second stage. In the third stage, 21 houses were selected randomly within each selected EB. If there was more than one household residing in the selected house, the interviewer would randomly select one household to participate. A household is defined as “a group of persons who normally live together and take their meals from the same kitchen (same cooking pot) unless the exigencies of work prevent any of them from doing so” (Population Census 2011, 2011). The interviewers then identified the head of household and all eligible women (non-pregnant women aged 18–49 years) residing in the household. When two or more eligible women were identified in a single household, one woman was chosen through a random selection process. If the selected household was not available at initial contact, two subsequent visits were made to check for availability before labeling the household as unavailable/nonresponsive. The same procedure was used for the selected woman, that is, if the selected woman was not available at initial contact, two more attempts were made on different occasions before labeling her as nonresponsive.

A total of 1148 households were needed to estimate a 50% prevalence of folate insufficiency or vitamin B12 deficiency and marginal deficiency at baseline and an expected post-intervention decrease in prevalence of 10%. The following parameters were used in the calculation of the minimum household sample size: study power: 80%, survey design effect: 2.0, household response rate: 90%, and response rate among non-pregnant women: 85%. Prior to data collection, ethical approval was obtained from the Institutional Ethics Committee at the Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh (India), No. PGI/IEC/2016/2170. The study protocol was also reviewed at the U.S. Centers for Disease Control and Prevention (CDC) and was determined to be a non-research, routine surveillance activity.

2.3 |. Informed Consent

Written informed consent (in Hindi) was obtained from all the participants prior to the start of data and blood collection. If the participants were unable to read, the interviewer/literate family member would read out the consent document and the participants could either sign the form or use a thumbprint.

2.4 |. Interview Data Collection

All interviews were conducted in the local language (Hindi) at the home of the participants by trained interviewers using structured questionnaires, which were first developed in English and translated into Hindi. The questionnaire had two parts. The household questionnaire collected socio-demographic data and information on participation in the governmental food security public distribution system (PDS), possession of a ration card issued by state governments that enables eligible households to obtain subsidized food from the PDS, and use of wheat grain and flour. Anyone ≥18 years could complete this questionnaire. The questionnaire for women included information on socio-demographics, reproductive and pregnancy history, health conditions, dietary habits, use of nutritional supplements, and medications and was administered to the selected non-pregnant WRA (18–49 years) in the household. Pregnancy status was determined by self-report.

2.5 |. Blood Collection, Processing, and Storage

Upon completion of the questionnaire for women, the interviewers described to the participants the blood collection process and provided information on the time and location for blood collection the following day. All blood collections occurred at a central location (e.g., community center/Anganwadi [rural childcare] center/health center or government school). Blood samples were collected from non-pregnant women aged 18–49 years using standardized protocols for laboratory safety and procedures. Women were not required to fast prior to blood collection. Additional details on blood collection, processing, and storage can be found in Appendix.

2.6 |. Biochemical Analysis

Biochemical analyses included serum and RBC folate and vitamin B12 concentrations. Serum and RBC folate concentrations were measured using the WHO-recommended microbiologic assay using the chloramphenicol-resistant strain of Lactobacillus rhamnosus and a 5-methyltetrahydrofolate calibrator provided by CDC. Serum vitamin B12 concentrations were assessed by the electrochemiluminescence technology-based immunoassay (Cobas e601, Roche analyzer series) using Roche analyzer FDA-approved kits.

2.7 |. Biochemical Indicators

Folate deficiency was defined as either serum folate <7 nmol/L or RBC folate <305 nmol/L (Pfeiffer et al. 2016; Institute of Medicine, Food and Nutrition Board 1998; World Health Organization 2015a, 2015b). Folate insufficiency was defined as RBC folate <748 nmol/L, the adjusted threshold for optimal NTD prevention (Pfeiffer et al. 2016, 2011; Crider et al. 2014; Tinker et al. 2015). Vitamin B12 deficiency was defined as vitamin B12 <200 pg/mL, and vitamin B12 marginal deficiency was defined as vitamin B12 ≥200 pg/mL and ≤300 pg/mL (Rosenthal et al. 2017). All women received written reports of their hemoglobin and vitamin B12 levels and beta thalassemia screening results. Women who had severe anemia (hemoglobin <8 g/dL), vitamin B12 deficiency (vitamin B12 <200 pg/mL), or were found to be a carrier for beta thalassemia were contacted by phone and referred to the nearest primary health center.

2.8 |. Survey Procedures

Quality assurance procedures were followed for each step of the study. Survey instruments were developed in consultation with experts and were pretested in a similar non-study community. Adequate training including practice interviews were imparted to field investigators for collecting household and women data. Questionnaires were checked for completeness and recording errors by field supervisors at the end of each visit and were returned to interviewers for corrections if necessary. When appropriate, households and women were contacted for follow-up. Laboratory technicians were trained for blood collection, processing, and documentation to ensure good laboratory practices. To ensure accuracy, dual data entry was conducted, and random checks were exercised by field supervisors.

2.9 |. Statistical Analysis

Analyses for this descriptive study included non-pregnant, non-lactating women. Frequencies, percentages, and 95% confidence intervals (CIs) were calculated for the following socio-demographic variables: age (18–29, 30–39, 40–49 years), religion (Hinduism, Islam, Sikhism), caste (official governmental classification: General, Scheduled [Caste, Tribe], Other Backward Classes), education (none, primary, secondary, higher secondary and above), occupation (earning, non-earning), marital status (never married, married, divorced/widowed/separated), and parity (nulliparous, primiparous, multiparous). We described the participants’ dietary preference as vegetarian, eggetarian (vegetarian who consumes eggs), non-vegetarian, having a functional/active ration card (yes, no), ration card category (below poverty line, above poverty line), PDS wheat purchase (yes, no), folic acid supplement use (yes, no), and vitamin B12 supplement use (yes, no). We calculated, for all variables, the unweighted sample size and weighted percentage and associated 95% CI. All analyses used the study design weights that were adjusted for non-response.

We calculated weighted RBC folate, serum folate, and serum vitamin B12 geometric means (GMs) and GM ratios (GMRs) and 95% CI for all variables using a linear model after natural log transformation. Prevalence estimates and 95% CI for folate deficiency (serum and RBC folate), RBC folate insufficiency, and serum vitamin B12 deficiency and marginal deficiency were calculated. We used a multivariable linear model to calculate the adjusted GMs and GMRs and logistic regression models to calculate the crude and adjusted prevalence ratios (PRs) comparing sub-categories within a variable. For both linear and logistic regression models, we used a stepwise procedure and only retained significant variables (p < 0.05) in the final multivariable model. In adjusted models, only parity was included if significant because parity and marital status were correlated.

We modeled the predicted NTD prevalence per 10,000 births based on RBC folate concentrations using the weighted distributions of RBC folate concentrations of the study population (Crider et al. 2014; Wang et al. 2021). All analyses were conducted using SAS-callable SUDAAN Version 11.0.4 (Research Triangle Park, NC).

3 |. Results

3.1 |. Response Rates

A total of 1155 houses were selected for the survey, and among 1130 eligible households, members from 1115 households (98.7%) participated in the survey. Among the surveyed households, there were 983 eligible non-pregnant WRA (18–49 years), of which 933 (94.9%) agreed to participate in the women’s questionnaire and 866 (88.1%) provided blood samples.

3.2 |. Characteristics of the Study Population

Blood samples were analyzed from 775 non-pregnant, non-lactating WRA.

Table 1 summarizes the characteristics of these WRA. Their mean age was 33.9 years (data not shown) and 71.1% were 18–39 years old. Among the participants, 88.9% were Hindu; 22.5% had no formal education, 37.8% finished secondary school, 18.0% had higher than secondary education; 68.0% were of a non-earning occupation (homemaker); and 13.6% were never married. Among married women, 82.0% had at least one child. Women were primarily vegetarian (85.4%). Almost all had a ration card (97.1%), and of those with a ration card, 63% were above the poverty line, and 37% were below the poverty line. Most women (65.0%) reported purchasing wheat from PDS fair price shops. Few of the women took folic acid (3.4%) or vitamin B12 (2.5%) supplements.

TABLE 1 |.

Population characteristics among non-pregnant and non-lactating women of reproductive age, 18–49 years, Ambala District, Haryana, India.

Characteristic n (unweighted) Weighted (%) 95% CI
Total 775
Age (years)
  18–29 249 31.3 28.0, 34.9
  30–39 307 39.8 36.1, 43.6
  40–49 219 28.9 25.5, 32.5
Religion
  Hinduism 693 88.9 86.6, 90.8
  Islam 22 2.9 1.9, 4.4
  Sikhism 60 8.2 6.5, 10.3
Caste
  General 229 29.1 26.2, 32.1
  Scheduled (caste, tribe) 279 33.2 30.4, 36.2
  Other backward classes 267 37.7 34.8, 40.7
Education
  None 160 22.5 19.3, 26.0
  Primary 155 21.7 18.7, 25.1
  Secondary 291 37.8 34.1, 41.6
  Higher secondary and above 137 18.0 15.3, 21.0
  Missing 32
Occupation
  Earning 248 32.0 28.5, 35.7
  Non-earning 513 68.0 64.3, 71.5
  Missing 14
Marital status
  Never married 109 13.6 11.2, 16.3
  Married 620 79.8 76.5, 82.7
  Divorced/widowed/separated 46 6.6 4.9, 8.9
Parity
  Nulliparous 145 18.0 15.4, 21.1
  Primiparous 79 10.1 8.0, 12.6
  Multiparous 551 71.9 68.4, 75.2
Diet
  Vegetarian 670 85.4 82.4, 88.0
  Eggetarian 36 4.7 3.4, 6.6
  Non-vegetarian 69 9.8 7.7, 12.5
Having a ration card
  Yes 755 97.1 95.3, 98.2
  No 20 2.9 1.8, 4.7
Ration card category
  Below poverty line 277 36.2 32.8, 39.7
  Above poverty line 477 60.9 57.2, 64.4
  No ration card 20 2.9 1.8, 4.7
  Missing 1
PDS wheat purchase
  Yes 497 65.0 61.4, 68.4
  No 255 32.1 28.8, 35.6
  No ration card 20 2.9 1.8, 4.7
  Missing 3
Folic acid supplement use
  Yes 23 3.4 2.2, 5.3
  No 752 96.6 94.7, 97.8
Vitamin B12 supplement use
  Yes 20 2.5 1.6, 4.0
  No 755 97.5 96.0, 98.4

Abbreviations: 95% CI, 95% confidence interval; PDS, public distribution system.

3.3 |. Folate Status

Unadjusted and adjusted geometric means (GMs) and GM ratios (GMRs) of RBC folate concentration are presented in Table 2, and the prevalence of RBC folate deficiency and unadjusted prevalence ratios (PRs) are presented in Table S1. The overall unadjusted and adjusted GMs of RBC folate concentration were 546.3 nmol/L (95% CI: 518.3, 575.8) and 544.5 nmol/L (95% CI: 518.3, 574.8), respectively (Table 2), and 9.3% (95% CI: 7.4, 11.6) of women had RBC folate deficiency (Table S1). RBC folate concentrations were higher in women aged 30–39 years (554.7 nmol/L) and 40–49 years (597.4 nmol/L) compared to women aged 18–29 years (495.1 nmol/L), and differences remained significant after adjustment (aGMR: 1.12 [1.02, 1.23] and aGMR: 1.21 [1.08, 1.35], respectively). Significant differences in GMs were also observed by parity status. Compared to nulliparous women (474.8 nmol/L), women who were primiparous (549.0 nmol/L) and multiparous (566.3 nmol/L) had higher RBC folate concentrations, and differences remained significant after adjustment (aGMR: 1.16 [1.00, 1.33] and aGMR: 1.19 [1.07, 1.33], respectively). Consumption of folic acid or vitamin B12 supplements resulted in higher RBC folate concentrations compared to women who reported no consumption (folic acid: 817.8 vs. 539.1 nmol/L and vitamin B12: 727.2 vs. 542.8 nmol/L), and differences remained significant after adjustment (folic acid: aGMR: 1.52 [1.18, 1.96] and vitamin B12: aGMR: 1.34 [1.00, 1.79]). The overall unadjusted and adjusted GMs of serum folate concentration were identical—12.4 nmol/L (95% CI: 11.9, 12.9; Table S2), and 10.1% (7.9, 12.7) of women had serum folate deficiency (Table S3). Compared to women aged 18–29 years (13.2 nmol/L), serum folate concentration was lower among women aged 40–49 years (11.2 nmol/L, aGMR: 0.85 [0.78, 0.93]). Compared to women with no education (11.9 nmol/L) and those reported not consuming folic acid supplements (12.3 nmol/L), those with higher than a secondary education (13.8 nmol/L, aGMR: 1.16 [1.03, 1.31]) and those who reported consuming folic acid supplements (18.9 nmol/L, aGMR: 1.54 [1.24, 1.91]) had higher serum folate concentrations. Compared to women aged 18–29 years (6.3%) and those who are Hindus (9.6%), serum folate deficiency was higher in women aged 30–39 years (11.0%), women aged 40–49 years (13.0%) and Muslims (28.0%), and differences remained significant after adjustment (30–39 years: aPR: 1.89 [1.02, 3.48]; 40–49 years: aPR: 2.20 [1.14, 4.25]; and Muslims: aPR: 3.29 [1.58, 6.84]).

TABLE 2 |.

Unadjusted and adjusted geometric means and geometric mean ratios of red blood cell folate concentrations among non-pregnant and non-lactating women of reproductive age, 18–49 years, Ambala District, Haryana, India.

RBC folate, nmol/L
Characteristic n (unweighted) Unadjusted geometric mean (95% CI) Unadjusted geometric mean ratio (95% CI) Adjusted geometric mean (95% CI)a Adjusted geometric mean ratio (95% CI)
Total 775 546.3 (518.3, 575.8) 544.5 (518.3, 574.8)
Age (years)
  18–29 249 464.9 (438.9, 492.4) Referent 495.1 (463.4, 528.9) Referent
  30–39 307 566.7 (535.5, 599.7) 1.22 (1.12, 1.32) 554.7 (522.4, 588.9) 1.12 (1.02, 1.23)
  40–49 219 621.0 (576.8, 668.6) 1.34 (1.22, 1.47) 597.4 (554.6, 643.6) 1.21 (1.08, 1.35)
Religion
  Hinduism 693 543.1 (523.2, 563.8) Referent
  Islam 22 514.6 (411.9, 643.1) 0.95 (0.76, 1.19)
  Sikhism 60 601.5 (514.5, 703.2) 1.11 (0.94, 1.30)
Caste
  General 229 567.5 (529.2, 608.7) Referent
  Scheduled (caste, tribe) 279 542.2 (507.2, 579.6) 0.96 (0.87, 1.05)
  Other backward classes 267 535.4 (506.8, 565.7) 0.94 (0.86, 1.03)
Education
  None 160 546.5 (509.1, 586.7) Referent
  Primary 155 564.3 (521.3, 610.9) 1.03 (0.93, 1.15)
  Secondary 291 530.1 (497.7, 564.6) 0.97 (0.88, 1.07)
  Higher secondary and above 137 549.8 (504.0, 599.7) 1.01 (0.90, 1.13)
Occupation
  Earning 248 547.3 (512.6, 584.4) Referent
  Non-earning 513 544.0 (520.4, 568.6) 0.99 (0.92, 1.08)
Marital status
  Never married 109 427.9 (388.3, 471.4) Referent
  Married 620 570.4 (547.9, 593.7) 1.33 (1.20, 1.48)
  Divorced/widowed/separated 46 545.1 (483.3, 614.7) 1.27 (1.09, 1.49)
Parity
  Nulliparous 145 434.3 (401.2, 470.2) Referent 474.8 (431.9, 522.0) Referent
  Primiparous 79 521.0 (465.0, 583.8) 1.20 (1.04, 1.38) 549.0 (489.9, 615.2) 1.16 (1.00 b , 1.33)
  Multiparous 551 583.3 (558.9, 608.8) 1.34 (1.23, 1.47) 566.3 (543.0, 590.5) 1.19 (1.07, 1.33)
Diet
  Vegetarian 670 541.9 (520.9, 563.7) Referent
  Eggetarian 36 519.0 (461.8, 583.2) 0.96 (0.85, 1.08)
  Non-vegetarian 69 607.3 (541.4, 681.2) 1.12 (0.99, 1.27)
Having a ration card
  Yes 755 547.4 (527.9, 567.7) 1.04 (0.85, 1.26)
  No 20 527.8 (434.7, 640.8) Referent
Ration card category
  Below poverty line 277 532.5 (502.8, 563.9) Referent
  Above poverty line 477 556.5 (530.3, 584.0) 1.05 (0.97, 1.13)
  No ration card 20 527.8 (434.7, 640.8) 0.99 (0.81, 1.21)
PDS wheat purchase
  Yes 497 539.5 (516.3, 563.7) 1.02 (0.84, 1.25)
  No 255 564.7 (528.4, 603.5) 1.07 (0.87, 1.32)
  No ration card 20 527.8 (434.7, 640.8) Referent
Folic acid supplement use
  Yes 23 863.6 (685.4, 1088.2) 1.61 (1.27, 2.03) 817.8 (637.4, 1049.4) 1.52 (1.18, 1.96)
  No 752 538.1 (519.3, 557.5) Referent 539.1 (520.8, 558.0) Referent
Vitamin B12 supplement use
  Yes 20 835.1 (623.6, 1118.5) 1.54 (1.15, 2.07) 727.2 (547.2, 966.3) 1.34 (1.00 b , 1.79)
  No 755 540.8 (522.0, 560.3) Referent 542.8 (524.6, 561.6) Referent

Note: Statistically significant results are bolded.

Abbreviations: 95% CI, 95% confidence interval; PDS, public distribution system; RBC, red blood cell.

a

Adjusted for age, parity, folic acid use, and vitamin B12 use.

b

Value >1.

3.4 |. Prevalence of RBC Folate Insufficiency and Predicted NTD Prevalence

The prevalence of RBC folate insufficiency and unadjusted and adjusted prevalence ratios (aPRs) are presented in Table 3. Overall, 78.3% (95% CI: 75.0, 81.3) of women had RBC folate insufficiency. The prevalence of RBC folate insufficiency was 90.2% among women aged 18–29 years and 95.5% among nulliparous women. Women aged 30–39 years (76.6%) and 40–49 years (67.8%) and women who were primiparous (78.6%) and multiparous (74.0%) had lower RBC folate insufficiency compared to women aged 18–29 years and nulliparous women. These differences remained significant after adjustment for women aged 40–49 years and those who were primiparous and multiparous (40–49 years: aPR: 0.84 [0.74, 0.95]; primiparous: aPR: 0.79 [0.67, 0.94]; multiparous: aPR: 0.82 [0.74, 0.90]). Women who reported consuming folic acid supplements had a lower prevalence of folate insufficiency (48.3%) compared to those who reported no consumption (79.4%), and the difference remained after adjustment (aPR: 0.58 [0.34, 0.99]). The overall predicted NTD prevalence per 10,000 births based on RBC folate concentrations was 21.0 (95% uncertainty interval [UI]: 16.9, 25.9).

TABLE 3 |.

Prevalence and unadjusted and adjusted prevalence ratios of red blood cell folate insufficiency among non-pregnant and non-lactating women of reproductive age, 18–49 years, Ambala District, Haryana, India.

RBC folate insufficiency (<748 nmol/L)
Characteristic n (unweighted) Prevalence (95% CI) Unadjusted prevalence ratio (95% CI) Adjusted prevalence ratio (95% CI)a
Total 775 78.3 (75.0, 81.3)
Age (years)
  18–29 249 90.2 (85.0, 93.7) Referent Referent
  30–39 307 76.6 (71.0, 81.5) 0.85 (0.78, 0.92) 0.92 (0.83, 1.02)
  40–49 219 67.8 (60.6, 74.3) 0.75 (0.67, 0.84) 0.84 (0.74, 0.95)
Religion
  Hinduism 693 79.1 (75.7, 82.2) Referent
  Islam 22 77.2 (53.9, 90.7) 0.98 (0.76, 1.25)
  Sikhism 60 70.2 (54.8, 82.1) 0.89 (0.72, 1.09)
Caste
  General 229 75.3 (68.5, 81.0) Referent
  Scheduled (caste, tribe) 279 77.4 (71.6, 82.3) 1.03 (0.92, 1.15)
  Other backward classes 267 81.6 (75.7, 86.2) 1.08 (0.97, 1.20)
Education
  None 160 78.9 (70.9, 85.2) Referent
  Primary 155 78.0 (70.0, 84.4) 0.99 (0.87, 1.13)
  Secondary 291 79.7 (74.3, 84.2) 1.01 (0.90, 1.13)
  Higher secondary and above 137 78.2 (69.7, 84.8) 0.99 (0.87, 1.13)
Occupation
  Earning 248 77.1 (70.9, 82.4) Referent
  Non-earning 513 79.1 (74.9, 82.8) 1.03 (0.94, 1.12)
Marital status
  Never married 109 94.7 (85.3, 98.2) Referent
  Married 620 75.7 (71.8, 79.2) 0.80 (0.74, 0.86)
  Divorced/widowed/separated 46 76.3 (61.6, 86.6) 0.81 (0.68, 0.96)
Parity
  Nulliparous 145 95.5 (88.5, 98.4) Referent Referent
  Primiparous 79 78.6 (66.1, 87.4) 0.82 (0.71, 0.95) 0.79 (0.67, 0.94)
  Multiparous 551 74.0 (69.8, 77.8) 0.77 (0.72, 0.83) 0.82 (0.74, 0.90)
Diet
  Vegetarian 670 78.8 (75.3, 82.0) Referent
  Eggetarian 36 87.5 (72.4, 95.0) 1.11 (0.98 1.26)
  Non-vegetarian 69 69.8 (56.5, 80.4) 0.88 (0.74, 1.06)
Having a ration card
  Yes 755 78.1 (74.7, 81.1) 0.89 (0.76, 1.05)
  No 20 87.6 (67.2, 96.0) Referent
Ration card category
  Below poverty line 277 80.4 (74.9, 85.0) Referent
  Above poverty line 477 76.6 (72.1, 80.6) 0.95 (0.88, 1.04)
  No ration card 20 87.6 (67.2, 96.0) 1.09 (0.92, 1.29)
PDS wheat purchase
  Yes 497 79.8 (75.7, 83.3) 0.91 (0.78, 1.07)
  No 255 74.7 (68.1, 80.3) 0.85 (0.72, 1.02)
  No ration card 20 87.6 (67.2, 96.0) Referent
Folic acid supplement use
  Yes 23 48.3 (27.5, 69.6) 0.61 (0.38, 0.97) 0.58 (0.34, 0.99)
  No 752 79.4 (76.1, 82.4) Referent Referent
Vitamin B12 supplement use
  Yes 20 62.7 (37.7, 82.3) 0.80 (0.54, 1.17)
  No 755 78.8 (75.4, 81.8) Referent

Note: Statistically significant results are bolded.

Abbreviations: 95% CI, 95% confidence interval; PDS, public distribution system; RBC, red blood cell.

a

Adjusted for age, parity, and folic acid use.

3.5 |. Serum Vitamin B12 Status

The overall unadjusted (190.4 pg/mL [95% CI: 180.6, 200.7]) and adjusted (188.6 pg/mL [178.8, 199.1]) GMs of serum vitamin B12 concentration were similar (Table 4), and 57.7% [53.9, 61.4] of women had serum vitamin B12 deficiency and 23.5% [20.4, 26.9] had marginal deficiency (Table 5). Compared to women aged 18–29 years (167.5 pg/mL), Hindus (183.7 pg/mL), and nulliparous women (152.5 pg/mL), the aGMs of serum vitamin B12 concentration were higher among women aged 40–49 years (224.3 pg/mL, aGMR: 1.34 [1.09, 1.64]), Muslims (274.1 pg/mL, aGMR: 1.49 [1.12, 1.98]) and Sikhs (264.2 pg/mL, aGMR: 1.44 [1.08, 1.92]), and women who were primiparous (224.9 pg/mL, aGMR: 1.47 [1.17, 1.85]) and multiparous (198.2 pg/mL, aGMR: 1.30 [1.09, 1.54]). Compared to women who reported no consumption of folic acid supplements (188.9 pg/mL) or vitamin B12 supplements (187.0 pg/mL), the aGMs of serum vitamin B12 concentration were higher among women who reported consuming folic acid supplements (278.4 pg/mL, aGMR: 1.47 [1.04, 2.09]) or vitamin B12 supplements (468.3 pg/mL, aGMR: 2.50 [1.51, 4.15]). Prevalence of serum vitamin B12 deficiency was lower among women aged 40–49 years (48.8%) compared to women aged 18–29 years (69.3%, aPR: 0.80 [0.64, 0.99]); Muslims (36.9%) and Sikhs (38.4%) compared to Hindus (60.2%, Muslims: aPR: 0.55 [0.30, 1.00] and Sikhs: aPR: 0.67 [0.49, 0.90]); multiparous women (53.1%) compared to nulliparous women (75.6%, aPR: 0.81 [0.65, 0.99]); and those who reported consuming vitamin B12 supplements (16.8%) compared to those who reported no consumption of vitamin B12 supplements (58.8%, aPR: 0.29 [0.12, 0.70]).

TABLE 4 |.

Unadjusted and adjusted geometric means and geometric mean ratios of serum vitamin B12 concentrations among non-pregnant and non-lactating women of reproductive age, 18–49 years, Ambala District, Haryana, India.

Characteristic n (unweighted) Serum vitamin B12, pg/dL
Unadjusted geometric mean (95% CI) Unadjusted geometric mean ratio (95% CI) Adjusted geometric mean (95% CI)a Adjusted geometric mean ratio (95% CI)
Total 755 190.4 (180.6, 200.7) 188.6 (178.8, 199.1)
Age (years)
  18–29 249 154.5 (142.3, 167.8) Referent 167.5 (150.7, 186.2) Referent
  30–39 307 193.7 (176.9, 212.1) 1.25 (1.11, 1.42) 189.6 (173.0, 207.8) 1.13 (0.97, 1.32)
  40–49 219 237.7 (206.3, 273.9) 1.54 (1.30, 1.81) 224.3 (194.7, 258.4) 1.34 (1.09, 1.64)
Religion
  Hinduism 693 183.5 (172.8, 194.9) Referent 183.7 (173.7, 194.2) Referent
  Islam 22 248.4 (186.7, 330.4) 1.35 (1.01, 1.81) 274.1 (207.6, 361.8) 1.49 (1.12, 1.98)
  Sikhism 60 276.5 (202.0, 378.4) 1.51 (1.09, 2.08) 264.2 (199.6, 349.7) 1.44 (1.08, 1.92)
Caste
  General 229 189.3 (170.1, 210.7) Referent
  Scheduled (caste, tribe) 279 188.5 (167.7, 212.0) 1.00 (0.85, 1.18)
  Other backward classes 267 196.5 (178.8, 216.0) 1.04 (0.90, 1.21)
Education
  None 160 200.9 (176.8, 228.3) Referent
  Primary 155 193.2 (169.6, 220.1) 0.96 (0.80, 1.15)
  Secondary 291 187.2 (169.0, 207.3) 0.93 (0.79, 1.10)
  Higher secondary and above 137 189.4 (159.0, 225.5) 0.94 (0.76, 1.17)
Occupation
  Earning 248 197.1 (175.2, 221.8) Referent
  Non-Earning 513 189.3 (176.0, 203.6) 0.96 (0.83, 1.11)
Marital status
  Never married 109 135.1 (121.0, 150.8) Referent
  Married 620 202.6 (188.7, 217.5) 1.50 (1.31, 1.72)
  Divorced/widowed/separated 46 197.9 (157.2, 249.1) 1.47 (1.13, 1.89)
Parity
  Nulliparous 145 132.9 (119.6, 147.8) Referent 152.5 (132.5, 175.5) Referent
  Primiparous 79 210.0 (160.6, 274.6) 1.58 (1.18, 2.12) 224.9 (175.5, 288.1) 1.47 (1.17, 1.85)
  Multiparous 551 207.1 (192.9, 222.3) 1.56 (1.37, 1.78) 198.2 (184.7, 212.6) 1.30 (1.09, 1.54)
Diet
  Vegetarian 670 187.0 (175.5, 199.2) Referent
  Eggetarian 36 178.5 (142.8, 223.1) 0.95 (0.76, 1.21)
  Non-vegetarian 69 243.2 (186.7, 316.7) 1.30 (0.99, 1.71)
Having a ration card
  Yes 755 191.2 (179.8, 203.2) 0.95 (0.77, 1.17)
  No 20 201.5 (164.6, 246.7) Referent
Ration card category
  Below poverty line 277 183.4 (169.0, 199.0) Referent
  Above poverty line 477 195.9 (179.5, 213.7) 1.07 (0.95, 1.21)
  No ration card 20 201.5 (164.6, 246.7) 1.10 (0.89, 1.36)
PDS wheat purchase
  Yes 497 184.6 (172.0, 198.1) 0.92 (0.74, 1.13)
  No 255 205.1 (180.8, 232.7) 1.02 (0.80, 1.29)
  No ration card 20 201.5 (164.6, 246.7) Referent
Folic acid supplement use
  Yes 23 331.5 (205.8, 534.0) 1.77 (1.09, 2.85) 278.4 (197.6, 392.2) 1.47 (1.04, 2.09)
  No 752 187.8 (177.0, 199.2) Referent 188.9 (178.7, 199.8) Referent
Vitamin B12 supplement use
  Yes 20 525.6 (295.5, 934.9) 2.82 (1.58, 5.04) 468.3 (283.4, 773.8) 2.50 (1.51, 4.15)
  No 755 186.5 (176.0, 197.6) Referent 187.0 (177.0, 197.6) Referent

Note: Statistically significant results are bolded.

Abbreviations: 95% CI, 95% confidence interval; PDS, public distribution system.

a

Adjusted for: Age, religion, parity, folic acid use, and vitamin B12 use.

TABLE 5 |.

Prevalence and unadjusted and adjusted prevalence ratios of vitamin B12 deficiency and marginal deficiency among non-pregnant and non-lactating women of reproductive age, 18–49 years, Ambala District, Haryana, India.

Serum vitamin B12 deficiency (<200 pg/mL)
Serum vitamin B12 marginal deficiency (≥200–<300 pg/mL)
Characteristic n (unweighted) Prevalence (95% CI) Unadjusted prevalence ratio (95% CI) Adjusted prevalence ratio (95% CI)a Prevalence (95% CI) Unadjusted prevalence ratio (95% CI) Adjusted prevalence ratio (95% CI)b
Total 755 57.7 (53.9, 61.4) 23.5 (20.4, 26.9)
Age (years)
  18–29 249 69.3 (62.8, 75.1) Referent Referent 18.8 (14.2, 24.4) Referent Referent
  30–39 307 55.1 (49.1, 60.9) 0.79 (0.69, 0.91) 0.86 (0.71, 1.05) 26.6 (21.5, 32.3) 1.42 (1.01, 1.99) 1.05 (0.68, 1.63)
  40–49 219 48.8 (41.5, 56.1) 0.70 (0.59, 0.84) 0.80 (0.64, 0.99) 24.5 (18.8, 31.4) 1.31 (0.90, 1.90) 0.96 (0.60, 1.54)
Religion
  Hinduism 693 60.2 (56.2, 64.0) Referent Referent 21.8 (18.6, 25.4) Referent Referent
  Islam 22 36.9 (19.5, 58.6) 0.61 (0.35, 1.07) 0.55 (0.30, 1.00 c ) 37.8 (19.5, 60.4) 1.73 (0.96, 3.13) 1.64 (0.86, 3.13)
  Sikhism 60 38.4 (26.7, 51.6) 0.64 (0.45, 0.89) 0.67 (0.49, 0.90) 36.9 (24.4, 51.5) 1.69 (1.13, 2.54) 1.57 (1.04, 2.37)
Caste
  General 229 54.1 (47.1, 60.9) Referent 28.6 (22.6, 35.4) Referent
  Scheduled (caste, tribe) 279 57.3 (51.0, 63.4) 1.06 (0.90, 1.26) 21.7 (16.8, 27.4) 0.76 (0.54, 1.05)
  Other backward classes 267 60.8 (54.2, 67.0) 1.12 (0.95, 1.33) 21.3 (16.3, 27.3) 0.74 (0.53, 1.05)
Education
  None 160 52.6 (44.3, 60.8) Referent 32.5 (25.0, 41.1) Referent Referent
  Primary 155 61.7 (53.2, 69.6) 1.17 (0.95, 1.44) 19.5 (13.5, 27.2) 0.60 (0.39, 0.92) 0.60 (0.39, 0.92)
  Secondary 291 57.4 (51.1, 63.4) 1.09 (0.90, 1.32) 21.3 (16.8, 26.8) 0.66 (0.47, 0.92) 0.66 (0.47, 0.93)
  Higher secondary and above 137 59.8 (50.9, 68.2) 1.14 (0.92, 1.41) 22.0 (15.5, 30.1) 0.68 (0.44, 1.03) 0.69 (0.45, 1.04)
Occupation
  Earning 248 54.9 (48.1, 61.5) Referent 25.8 (20.2, 32.2) Referent
  Non-earning 513 58.9 (54.2, 63.4) 1.07 (0.93, 1.24) 22.7 (19.0, 27.0) 0.88 (0.66, 1.19)
Marital status
  Never married 109 78.7 (68.7, 86.1) Referent 12.5 (7.2, 20.8) Referent
  Married 620 54.0 (49.7, 58.2) 0.69 (0.60, 0.79) 25.7 (22.1, 29.7) 2.06 (1.19, 3.57)
  Divorced/widowed/separated 46 59.5 (44.0, 73.4) 0.76 (0.57, 1.00c) 20.2 (10.8, 34.7) 1.62 (0.74, 3.56)
Parity
  Nulliparous 145 75.6 (67.0, 82.6) Referent Referent 14.7 (9.3, 22.5) Referent Referent
  Primiparous 79 58.4 (46.1, 69.7) 0.77 (0.61, 0.97) 0.81 (0.63, 1.04) 22.9 (14.5, 34.2) 1.55 (0.84, 2.88) 1.47 (0.79, 2.73)
  Multiparous 551 53.1 (48.6, 57.6) 0.70 (0.61, 0.80) 0.81 (0.65, 0.99) 25.8 (22.0, 30.1) 1.75 (1.10, 2.80) 1.70 (1.08, 2.68)
Diet
  Vegetarian 670 58.8 (54.8, 62.8) Referent 23.1 (19.7, 26.7) Referent
  Eggetarian 36 51.8 (34.6, 68.7) 0.88 (0.62, 1.25) 37.3 (21.8, 55.9) 1.62 (0.98, 2.66)
  Non-vegetarian 69 50.8 (38.0, 63.5) 0.86 (0.66, 1.13) 21.1 (12.4, 33.5) 0.91 (0.54, 1.55)
Having a ration card
  Yes 755 58.0 (54.2, 61.7) 1.20 (0.73, 1.96) 23.2 (20.0, 26.6) 0.64 (0.33, 1.27)
  No 20 48.5 (26.7, 70.9) Referent 36.0 (16.6, 61.4) Referent
Ration card category
  Below poverty line 277 58.2 (51.8, 64.3) Referent 24.3 (19.2, 30.2) Referent
  Above poverty line 477 57.8 (52.9, 62.5) 0.99 (0.87, 1.14) 22.5 (18.7, 26.9) 0.93 (0.69, 1.24)
  No ration card 20 48.5 (26.7, 70.9) 0.83 (0.50, 1.38) 36.0 (16.6, 61.4) 1.48 (0.73, 3.00)
PDS wheat purchase
  Yes 497 59.4 (54.7, 63.9) 1.22 (0.75, 2.01) 23.0 (19.2, 27.3) 0.64 (0.32, 1.27)
  No 255 55.4 (48.5, 62.0) 1.14 (0.69, 1.89) 23.0 (17.8, 29.2) 0.64 (0.32, 1.29)
  No ration card 20 48.5 (26.7, 70.9) Referent 36.0 (16.6, 61.4) Referent
Folic acid supplement use
  Yes 23 33.8 (17.5, 55.3) 0.58 (0.32, 1.04) 14.7 (4.5, 38.6) 0.62 (0.20, 1.87)
  No 752 58.6 (54.7, 62.3) Referent 23.8 (20.7, 27.3) Referent
Vitamin B12 supplement use
  Yes 20 16.8 (6.5, 37.0) 0.29 (0.12, 0.70) 0.29 (0.12, 0.70) 15.6 (5.6, 36.5) 0.66 (0.25, 1.72)
  No 755 58.8 (55.0, 62.5) Referent Referent 23.7 (20.6, 27.2) Referent

Note: Statistically significant results are bolded.

Abbreviations: 95% CI, 95% confidence interval; PDS, public distribution system.

a

Adjusted for age, religion, parity, and vitamin B12 use.

b

Adjusted for religion, education, and parity.

c

Value >1.

4 |. Discussion

This is the first population-based survey to provide blood folate and vitamin B12 status among non-pregnant, non-lactating WRA in Ambala District, Haryana, India. The prevalence of serum and RBC folate deficiency were 10.1% and 9.3%, respectively. Almost 80% of WRA had RBC folate insufficiency (RBC folate concentrations below the WHO threshold for optimal NTD prevention), 57.7% had vitamin B12 deficiency, and 23.5% had vitamin B12 marginal deficiency.

RBC folate insufficiency is associated with increased risk for NTDs at a population level (Crider et al. 2014). The prevalence of RBC folate insufficiency found in our study was very similar to the prevalence reported in a study from South India (79.3%) (Finkelstein et al. 2021). The method used to assess RBC folate insufficiency in these two studies was very similar. Both studies used the same WHO recommended microbiologic assay method, the same cut-off (<748 nmol/L for RBC folate insufficiency), and the same exclusion of pregnant and lactating women. Although several countries assessed RBC folate status in WRA, only few countries (United States, Belize, Guatemala, Ireland, New Zealand, and the United Kingdom) used the same microbiologic assay method and corresponding cut-off values as those used in the two Indian surveys (Pfeiffer et al. 2019) enabling comparable comparisons. The prevalence of RBC folate insufficiency reported in our study as well as in the study from South India were higher compared to those reported in the United States (18.6% in 2011–2016), Guatemala (47.2% in 2009–2010), Belize (48.9% in 2011), Ireland (64% in 2008–2010), and New Zealand (73% in 2008–2009) (Pfeiffer et al. 2019; Rosenthal et al. 2016, 2017; Hopkins et al. 2015; University of Otago 2011). In the United States, the prevalence was assessed post mandatory folic acid fortification while folic acid fortification was voluntary in the other four countries when the prevalence was assessed. There was no folic acid fortification in the United Kingdom at the time of assessment and the prevalence of RBC folate insufficiency was reported to be 91% (Public Health England 2018). One region in Guatemala was found to also have a high prevalence of RBC folate insufficiency (88.8%) and was thought to have limited access to fortified staples (Rosenthal et al. 2016). In our study, the prevalence of RBC folate insufficiency varied by age, parity, and folic acid supplement use. The prevalence was higher among WRA who were younger, nulliparous, and not reported to have used folic acid supplements; these findings are consistent with previously reported findings in South India (Finkelstein et al. 2021).

Using the RBC folate distribution, the predicted NTD prevalence in our study population (21.0 per 10,000 live births) was very similar to the estimated NTD prevalence found in South India where folic acid fortification program had not been implemented (20.6 per 10,000 live births) (Finkelstein et al. 2021). However, our estimated NTD prevalence is lower than the national pooled estimates. Comparability is challenging since these estimates relied on data using varying case definitions, types of hospitals, and time periods. A region in Guatemala where the population was thought to have limited access to fortified staples reported an even higher estimated NTD prevalence (26 per 10,000 live births) (Rosenthal et al. 2016). The estimated NTD prevalence in our study population was much higher than in countries with mandatory folic acid fortification, for example, 7.3 per 10,000 live births in the United States and 11 per 10,000 live births in the Metropolitan region of Guatemala where the population likely had access to fortified wheat flour (Crider et al. 2018; Rosenthal et al. 2016).

Serum folate is supposed to reflect recent intake, while RBC folate reflects intake over 120 days. In our study, the prevalence of folate deficiency was similar in the two media (10.1% in serum and 9.3% in RBC). Different methods and cut-offs are used for folate deficiency globally, making comparisons of estimates challenging. However, the study in South India did use the same methodology and cut-offs and serum and RBC folate deficiency were both higher in our study compared to findings from South India (serum folate deficiency 3.5% and RBC folate deficiency 7.6%) (Finkelstein et al. 2021). RBC folate deficiency in our study did not vary significantly among different characteristics. Studies in both China (Chen et al. 2019>) and South India (Fothergill et al. 2023) highlight that a serum folate insufficiency threshold should not be used to estimate NTD prevalence in populations with vitamin B12 deficiency and insufficiency. Thus, serum folate insufficiency was not used to estimate NTD prevalence in our study.

The prevalence of vitamin B12 deficiency in our study (57.7%) is one of the highest reported among WRA globally and was comparable to findings from other studies in India (42% in rural areas in Nagpur district, Maharashtra; 45% in rural areas in Mahbubnagar district, Telangana; 48.3% in South India; 50% in Pune, Maharashtra) and Pakistan (52.4% from a national survey) (Yajnik et al. 2008; Barney et al. 2020; Menon et al. 2011; Singh et al. 2017; Finkelstein et al. 2021; Naik, Mahalle, and Bhide 2018; Soofi et al. 2017). The prevalence of vitamin B12 deficiency in our study was higher among WRA who were younger, Hindus, nulliparous, and not reported to have used vitamin B12 supplements. These findings are consistent with findings from other studies (Sivaprasad et al. 2016; Finkelstein et al. 2021). Although women who reported to be vegetarians in our study had a higher prevalence of vitamin B12 deficiency (58.8%), it was not significantly higher than those who reported to be eggetarians (51.8%) and non-vegetarians (50.8%), who also appeared to have high prevalence of vitamin B12 deficiency. Although it was surprising to see the high prevalence of vitamin B12 deficiency among eggetarians and non-vegetarians in our study, this could be associated with the low frequency of animal-source foods (ASFs) consumption in the eggetarians and non-vegetarians, as low ASFs consumption had been identified as a risk factor for vitamin B12 deficiency (Green et al. 2017). This is also seen in other studies in India where a high prevalence of vitamin B12 insufficiency was reported among non-vegetarians (Finkelstein et al. 2021). In addition, a self-reported vegetarian diet had previously been reported to not be significantly associated with lower vitamin B12 concentrations (Menon et al. 2011). Women who were Hindus in our study had a significantly higher prevalence of vitamin B12 deficiency (60.2%) compared to women who were Muslims (36.9%) and Sikhs (38.4%). Different religious dietary rules have been reported to be risk factors for nutritional inadequacies or malnutrition, particularly in populations who consume no meat and/or poor dairy product intake (Chouraqui et al. 2021). The prevalence of vitamin B12 marginal deficiency in our study was 23.5%; hence vitamin B12 insufficiency was 81.2% (deficiency+marginal deficiency).

Our findings of the high baseline burden of RBC folate insufficiency and vitamin B12 deficiency/insufficiency suggest fortification with folic acid and vitamin B12 could reduce the prevalence of these micronutrient insufficiencies/deficiencies as had been observed in other countries (Das et al. 2013; Cordero, Do, and Berry 2008; López-Camelo et al. 2005; Sayed et al. 2008; Calvo and Biglieri 2008; Williams et al. 2002; Liu et al. 2004; Persad et al. 2002; De Wals et al. 2003; Ray et al. 2002). Given that the consumption of wheat in Haryana was >300 g/per capita/day, opportunities exist to fortify wheat flour to increase the intake of folic acid, vitamin B12, and other micronutrients among the populations in Haryana (Food Fortification Initiative 2016).

Our study is the first to provide representative population-based estimates on folate and vitamin B12 status among non-pregnant, non-lactating WRA in the rural Ambala District, Haryana. These results will serve as a baseline against which results from future post-fortification surveys can be compared. It is also the first study in North India to use distributions of RBC folate concentrations as measured by the microbiologic assay among WRA in rural Ambala District to estimate the predicted NTD prevalence in the population. Predicted prevalence of NTDs using RBC folate concentrations is valuable because there are presently no published studies on actual population estimates of NTDs in the study area. Our study was designed and implemented using a reliable population-based sampling design to reduce biases in the selection of households and individuals. Strict field and laboratory methodologies and rigorous protocols were used for survey administration and to ensure proper handling of biological samples. Folate analysis was performed using the WHO recommended microbiologic assay which enabled us to compare our findings with other studies that also used the same assay. Participation rates for both questionnaire and blood sample collection were high in our study.

Our study has several limitations. The cross-sectional survey design could not be used to determine causation. Because dietary intake data were not collected on folic acid or vitamin B12, we are unable to assess the causes of some of the disparities in observed deficiency and insufficiency. Our study only measured serum vitamin B12 status and other forms of vitamin B12 (e.g., methylmalonic acid, holo-transcobalamin) were not assessed.

In conclusion, this population-based cross-sectional study provides baseline pre-fortification measures of folate and vitamin B12 status among non-pregnant, non-lactating WRA in Haryana, India against which results from future post -fortification surveys can be compared. In our study, almost 80% of non-pregnant, non-lactating women in rural Ambala District, Haryana had RBC folate insufficiency with an estimated NTD prevalence of 21 per 10,000 live births. In addition, almost 60% of WRA had vitamin B12 deficiency, and 80% had vitamin B12 insufficiency.

Supplementary Material

SUP - Das - Folate and Vitamin B12 Status in Women of Reproductive Age in Rural Haryana India

Acknowledgments

This survey is a collaborative effort of the National Health Mission (NHM), Health Department, Government of Haryana, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, World Health Organization (WHO), and United States Centers for Disease Control and Prevention (CDC). The authors thank the members of the survey team for their work conducting the survey and the people of Ambala District for their participation in the survey. The authors wish to acknowledge the strong support from the government officials from the NHM, Haryana as well as from the Ambala District administration and health government, including community health workers and Panchayati Raj Institutions representatives at local level. We also thank Dr. Arick Wang for his time and analytical support in verifying the NTD predictions analyses, Dr. Mary Serdula for her technical assistance and leadership and Dr. Michael Cannon for his leadership. U.S. Centers for Disease Control and Prevention provided funding and technical assistance for the household and biomarker survey.

Funding:

This work was supported by US Centers for Disease Control and Prevention, Atlanta, GA, USA.

The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the U.S. Centers for Disease Control and Prevention.

Appendix

Blood Collection, Processing, and Storage

For each participant, venous blood samples (12 mL) were collected in two EDTA coated vacutainer and one non-coated vacutainer for serum separation. The collected blood samples were stored immediately at optimal cold chain (between 4 and 8°C) to ensure minimal sample degradation during transport to either a regional hospital laboratory for processing or directly to the PGIMER Department of Hematology Laboratory in Chandigarh. Samples processed at the regional hospital laboratory were transported to the PGIMER Department of Hematology Laboratory in Chandigarh in portable freezers twice a week at −20°C. Sample processing included preparing aliquots of hemolysates in freshly prepared ascorbic acid as per CDC protocol for the microbiologic assay for red blood cell (RBC) folate assessment, separation of serum, and aliquoting samples. All sample aliquots awaiting transport to PGIMER were stored at −20°C. Precautions were taken to ensure that the blood samples were not exposed to bright light. Complete hemogram was performed using the hematology analyzer—Sysmex XP 100 for hemoglobin (Hb) estimation and automated red cell indices. Hematocrit obtained from the hemogram was used to calculate the final RBC folate concentration. Once at PGIMER, the samples were stored at −80°C or less until batch analysis.

Biochemical Analysis

Both internal quality control as well as external quality assessment scheme from CDC (CDC VITAL-EQA) were used to ensure the quality of the RBC and serum folate results. CDC provided logistical support, and internal quality control (QC) pools were set up at PGIMER before performing analyses on the study samples (Das et al. 2017). QC pools for low and high whole-blood and serum folate concentrations were prepared and aliquots stored at −80°C. For each run, a standard growth curve of the organisms was prepared. Four replicates were run for each individual sample to calculate a robust mean concentration. The growth of the organisms was read as turbidity after incubating at 37°C for 40–42 h. The intra- and inter- assay coefficients of variation (CVs) for the high serum folate QC were 7.1% and 7.4%, respectively and for the low serum folate QC were 6.3% and 9.4%, respectively. The intra- and inter-assay CVs for the high whole blood lysate (WBL) folate QC were 6.8% and 7.7%, respectively and for the low WBL folate QC were 6.7% and 9.8%, respectively. The intra- and inter-assay CVs for the high serum vitamin B12 QC were 2.3% and 5.4%, respectively and for the low serum vitamin B12 QC were 1.9% and 7.4%, respectively.

Footnotes

Supporting Information

Additional supporting information can be found online in the Supporting Information section.

Conflicts of Interest

The authors declare no conflicts of interest.

Data Availability Statement

Research data are not shared.

References

  1. Allagh KP, Shamanna BR, Murthy GV, et al. 2015. “Birth Prevalence of Neural Tube Defects and Orofacial Clefts in India: A Systematic Review and Meta-Analysis.” PLoS One 10, no. 3: e0118961. 10.1371/journal.pone.0118961. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Atta CA, Fiest KM, Frolkis AD, et al. 2016. “Global Birth Prevalence of Spina Bifida by Folic Acid Fortification Status: A Systematic Review and Meta-Analysis.” American Journal of Public Health 106, no. 1: e24–e34. 10.2105/ajph.2015.302902. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bailey LB, and Hausman DB. 2018. “Folate Status in Women of Reproductive Age as Basis of Neural Tube Defect Risk Assessment.” Annals of the New York Academy of Sciences 1414, no. 1: 82–95. 10.1111/nyas.13511. [DOI] [PubMed] [Google Scholar]
  4. Barney AM, Abraham VJ, Danda S, Cherian AG, and Vanitha S. 2020. “Prevalence of Vitamin B12 Deficiency and Its Associated Risk Factors Among Pregnant Women of Rural South India: A Community-Based Cross-Sectional Study.” Indian Journal of Community Medicine 45, no. 4: 399–404. 10.4103/ijcm.IJCM_403_19. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Berry RJ, Li Z, Erickson JD, et al. 1999. “Prevention of Neural-Tube Defects With Folic Acid in China. China-U.S. Collaborative Project for Neural Tube Defect Prevention.” New England Journal of Medicine 341, no. 20: 1485–1490. 10.1056/nejm199911113412001. [DOI] [PubMed] [Google Scholar]
  6. Bhide P, Sagoo GS, Moorthie S, Burton H, and Kar A. 2013. “Systematic Review of Birth Prevalence of Neural Tube Defects in India.” Birth Defects Research. Part A, Clinical and Molecular Teratology 97, no. 7: 437–443. 10.1002/bdra.23153. [DOI] [PubMed] [Google Scholar]
  7. Blencowe H, Cousens S, Modell B, and Lawn J. 2010. “Folic Acid to Reduce Neonatal Mortality From Neural Tube Disorders.” International Journal of Epidemiology 39, no. S1: i110–i121. 10.1093/ije/dyq028. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Blencowe H, Kancherla V, Moorthie S, Darlison MW, and Modell B. 2018. “Estimates of Global and Regional Prevalence of Neural Tube Defects for 2015: A Systematic Analysis.” Annals of the New York Academy of Sciences 1414, no. 1: 31–46. 10.1111/nyas.13548. [DOI] [PubMed] [Google Scholar]
  9. Calvo EB, and Biglieri A. 2008. “Impacto de la fortificación conácido fólico sobre el estado nutricional en mujeres y la prevalencia de defectos del tubo neural [Impact of Folic Acid Fortification on Women’s Nutritional Status and on the Prevalence of Neural Tube Defects].” Archivos Argentinos de Pediatría 106, no. 6: 492–498. 10.1590/s0325-00752008000600004. [DOI] [PubMed] [Google Scholar]
  10. Centers for Disease Control and Prevention. 1992. “Recommendations for the Use of Folic Acid to Reduce the Number of Cases of Spina Bifida and Other Neural Tube Defects.” MMWR – Recommendations and Reports 41, no. Rr-14: 1–7. [PubMed] [Google Scholar]
  11. Chen MY, Rose CE, Qi YP, et al. 2019. “Defining the Plasma Folate Concentration Associated With the Red Blood Cell Folate Concentration Threshold for Optimal Neural Tube Defects Prevention: A Population-Based, Randomized Trial of Folic Acid Supplementation.” American Journal of Clinical Nutrition 109, no. 5: 1452–1461. 10.1093/ajcn/nqz027. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Chouraqui JP, Turck D, Briend A, et al. 2021. “Religious Dietary Rules and Their Potential Nutritional and Health Consequences.” International Journal of Epidemiology 50, no. 1: 12–26. 10.1093/ije/dyaa182. [DOI] [PubMed] [Google Scholar]
  13. Cordero AM, Crider KS, Rogers LM, Cannon MJ, and Berry RJ. 2015. “Optimal Serum and Red Blood Cell Folate Concentrations in Women of Reproductive Age for Prevention of Neural Tube Defects: World Health Organization Guidelines.” MMWR. Morbidity and Mortality Weekly Report 64, no. 15: 421–423. [PMC free article] [PubMed] [Google Scholar]
  14. Cordero JF, Do A, and Berry RJ. 2008. “Review of Interventions for the Prevention and Control of Folate and Vitamin B12 Deficiencies.” Food and Nutrition Bulletin 29, no. S2: S188–S195. 10.1177/15648265080292s122. [DOI] [PubMed] [Google Scholar]
  15. Crider KS, Devine O, Hao L, et al. 2014. “Population Red Blood Cell Folate Concentrations for Prevention of Neural Tube Defects: Bayesian Model.” British Medical Journal 349: g4554. 10.1136/bmj.g4554. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Crider KS, Qi YP, Devine O, Tinker SC, and Berry RJ. 2018. “Modeling the Impact of Folic Acid Fortification and Supplementation on Red Blood Cell Folate Concentrations and Predicted Neural Tube Defect Risk in the United States: Have We Reached Optimal Prevention?” American Journal of Clinical Nutrition 107, no. 6: 1027–1034. 10.1093/ajcn/nqy065. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Crider KS, Qi YP, Yeung LF, et al. 2022. “Folic Acid and the Prevention of Birth Defects: 30 Years of Opportunity and Controversies.” Annual Review of Nutrition 42, no. 1: 423–452. 10.1146/annurev-nutr-043020-091647. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Czeizel AE, and Dudás I. 1992. “Prevention of the First Occurrence of Neural-Tube Defects by Periconceptional Vitamin Supplementation.” New England Journal of Medicine 327, no. 26: 1832–1835. 10.1056/nejm199212243272602. [DOI] [PubMed] [Google Scholar]
  19. Das JK, Salam RA, Kumar R, and Bhutta ZA. 2013. “Micronutrient Fortification of Food and Its Impact on Woman and Child Health: A Systematic Review.” Systematic Reviews 2: 67. 10.1186/2046-4053-2-67. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Das R, Duggal M, Senee H, et al. 2017. “Laboratory Capacity-Building Initiative to Assess Folate Status in Women of Reproductive Age From Haryana, India: The Collaborative Experience of Local and International Partners.” Blood Advances 1, no. S1: 49–51. 10.1182/bloodadvances.2017GS99944. [DOI] [Google Scholar]
  21. De Wals P, Rusen ID, Lee NS, Morin P, and Niyonsenga T. 2003. “Trend in Prevalence of Neural Tube Defects in Quebec.” Birth Defects Research. Part A, Clinical and Molecular Teratology 67, no. 11: 919–923. 10.1002/bdra.10124. [DOI] [PubMed] [Google Scholar]
  22. Finkelstein JL, Fothergill A, Johnson CB, et al. 2021. “Anemia and Vitamin B-12 and Folate Status in Women of Reproductive Age in Southern India: Estimating Population-Based Risk of Neural Tube Defects.” Current Developments in Nutrition 5, no. 5: nzab069. 10.1093/cdn/nzab069. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Finkelstein JL, Layden AJ, and Stover PJ. 2015. “Vitamin B-12 and Perinatal Health.” Advances in Nutrition 6, no. 5: 552–563. 10.3945/an.115.008201. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Food Fortification Initiative. 2016. State of Haryana, India Wheat Flour Supply Chain Analysis, 1–38. Atlanta, GA: Food Fortification Initiative. https://static1.squarespace.com/static/5e1df234eef02705f5446453/t/60aeb1ea214a6f0d3995ae9e/1622061551362/Haryana_Fortification_Status_2016.pdf. [Google Scholar]
  25. Fothergill A, Crider KS, Rose CE, et al. 2023. “Estimating the Serum Folate Concentration That Corresponds to the Red Blood Cell Folate Concentration Threshold Associated With Optimal Neural Tube Defects Prevention: A Population-Based Biomarker Survey in Southern India.” American Journal of Clinical Nutrition 117, no. 5: 985–997. 10.1016/j.ajcnut.2023.01.016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Green R, Allen LH, Bjørke-Monsen AL, et al. 2017. “Vitamin B(12) Deficiency.” Nature Reviews. Disease Primers 3: 17040. 10.1038/nrdp.2017.40. [DOI] [PubMed] [Google Scholar]
  27. Henderson RH, and Sundaresan T. 1982. “Cluster Sampling to Assess Immunization Coverage: A Review of Experience With a Simplified Sampling Method.” Bulletin of the World Health Organization 60, no. 2: 253–260. [PMC free article] [PubMed] [Google Scholar]
  28. Hopkins SM, Gibney MJ, Nugent AP, et al. 2015. “Impact of Voluntary Fortification and Supplement Use on Dietary Intakes and Biomarker Status of Folate and Vitamin B-12 in Irish Adults.” American Journal of Clinical Nutrition 101, no. 6: 1163–1172. 10.3945/ajcn.115.107151. [DOI] [PubMed] [Google Scholar]
  29. Institute of Medicine; Food and Nutrition Board; Standing Committee on the Scientific Evaluation of Dietary Reference Intakes and its Panel on Folate, Other B Vitamins, and Choline; Subcommittee on Upper Reference Levels of Nutrients. 1998. “The National Academies Collection: Reports Funded by National Institutes of Health.” In Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B(6), Folate, Vitamin B(12), Pantothenic Acid, Biotin, and Choline. Washington, DC: National Academies Press (US). 10.17226/6015. [DOI] [PubMed] [Google Scholar]
  30. Keats EC, Neufeld LM, Garrett GS, Mbuya MNN, and Bhutta ZA. 2019. “Improved Micronutrient Status and Health Outcomes in Low- and Middle-Income Countries Following Large-Scale Fortification: Evidence From a Systematic Review and Meta-Analysis.” American Journal of Clinical Nutrition 109, no. 6: 1696–1708. 10.1093/ajcn/nqz023. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Liu S, West R, Randell E, et al. 2004. “A Comprehensive Evaluation of Food Fortification With Folic Acid for the Primary Prevention of Neural Tube Defects.” BMC Pregnancy and Childbirth 4, no. 1: 20. 10.1186/1471-2393-4-20. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Lo A, Polšek D, and Sidhu S. 2014. “Estimating the Burden of Neural Tube Defects in Low- and Middle-Income Countries.” Journal of Global Health 4, no. 1: 010402. 10.7189/jogh.04.010402. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. López-Camelo JS, Orioli IM, da Graça Dutra M, et al. 2005. “Reduction of Birth Prevalence Rates of Neural Tube Defects After Folic Acid Fortification in Chile.” American Journal of Medical Genetics. Part A 135, no. 2: 120–125. 10.1002/ajmg.a.30651. [DOI] [PubMed] [Google Scholar]
  34. Menon KC, Skeaff SA, Thomson CD, et al. 2011. “Concurrent Micronutrient Deficiencies Are Prevalent in Nonpregnant Rural and Tribal Women From Central India.” Nutrition 27, no. 4: 496–502. 10.1016/j.nut.2010.02.012. [DOI] [PubMed] [Google Scholar]
  35. Ministry of Health & Family Welfare, Government of India. 2022. “National Family Health Survey (NFHS-5) 2019–21 Compendium of Fact Sheets. Key Indicators India and 14 states/UTs (Phase-11).” https://rchiips.org/nfhs/NFHS-5_FCTS/Final%20Compendium%20of%20fact%20sheets_India%20and%2014%20States_UTs%20(Phase-II).pdf.
  36. Molloy AM 2018. “Should Vitamin B(12) Status Be Considered in Assessing Risk of Neural Tube Defects?” Annals of the New York Academy of Sciences 1414, no. 1: 109–125. 10.1111/nyas.13574. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Molloy AM, Kirke PN., Brody LC, Scott JM, and Mills JL. 2008. “Effects of Folate and Vitamin B12 Deficiencies During Pregnancy on Fetal, Infant, and Child Development.” Food and Nutrition Bulletin 29, no. 2 Suppl: S101–S115. 10.1177/15648265080292S114. [DOI] [PubMed] [Google Scholar]
  38. Molloy AM, Kirke PN, Troendle JF, et al. 2009. “Maternal Vitamin B12 Status and Risk of Neural Tube Defects in a Population With High Neural Tube Defect Prevalence and No Folic Acid Fortification.” Pediatrics 123, no. 3: 917–923. 10.1542/peds.2008-1173. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. MRC Vitamin Study Research Group. 1991. “Prevention of Neural Tube Defects: Results of the Medical Research Council Vitamin Study.” Lancet 338, no. 8760: 131–137. [PubMed] [Google Scholar]
  40. Naik S, Mahalle N, and Bhide V. 2018. “Identification of Vitamin B12 Deficiency in Vegetarian Indians.” British Journal of Nutrition 119, no. 6: 629–635. 10.1017/s0007114518000090. [DOI] [PubMed] [Google Scholar]
  41. Persad VL, Van den Hof MC, Dubé JM, and Zimmer P. 2002. “Incidence of Open Neural Tube Defects in Nova Scotia After Folic Acid Fortification.” Canadian Medical Association Journal 167, no. 3: 241–245. [PMC free article] [PubMed] [Google Scholar]
  42. Pfeiffer CM, Sternberg MR, Hamner HC, et al. 2016. “Applying Inappropriate Cutoffs Leads to Misinterpretation of Folate Status in the US Population.” American Journal of Clinical Nutrition 104, no. 6: 1607–1615. 10.3945/ajcn.116.138529. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Pfeiffer CM, Sternberg MR, Zhang M, et al. 2019. “Folate Status in the US Population 20 y After the Introduction of Folic Acid Fortification.” American Journal of Clinical Nutrition 110, no. 5: 1088–1097. 10.1093/ajcn/nqz184. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Pfeiffer CM, Zhang M, Lacher DA, et al. 2011. “Comparison of Serum and Red Blood Cell Folate Microbiologic Assays for National Population Surveys.” Journal of Nutrition 141, no. 7: 1402–1409. 10.3945/jn.111.141515. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Population Census 2011. 2011. “Ambala District – Population 2011.” https://www.census2011.co.in/census/district/209-ambala.html.
  46. Public Health England. 2018. “National Diet and Nutrition Survey: Results from Years 7 and 8 (Combined) of the Rolling Programme (2014/2015–2015/2016).” https://www.gov.uk/government/statistics/ndns-results-from-years-7-and-8-combined.
  47. Ray JG, Meier C, Vermeulen MJ, Boss S, Wyatt PR, and Cole DE. 2002. “Association of Neural Tube Defects and Folic Acid Food Fortification in Canada.” Lancet 360, no. 9350: 2047–2048. 10.1016/s0140-6736(02)11994-5. [DOI] [PubMed] [Google Scholar]
  48. Ray JG, Wyatt PR, Thompson MD, et al. 2007. “Vitamin B12 and the Risk of Neural Tube Defects in a Folic-Acid-Fortified Population.” Epidemiology 18, no. 3: 362–366. 10.1097/01.ede.0000257063.77411.e9. [DOI] [PubMed] [Google Scholar]
  49. Rosenthal J, Largaespada N, Bailey LB, et al. 2017. “Folate Deficiency Is Prevalent in Women of Childbearing Age in Belize and Is Negatively Affected by Coexisting Vitamin B-12 Deficiency: Belize National Micronutrient Survey 2011.” Journal of Nutrition 147, no. 6: 1183–1193. 10.3945/jn.116.242628. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Rosenthal J, Reeve ME, Ramirez N, et al. 2016. “Red Blood Cell Folate Insufficiency Among Nonpregnant Women of Childbearing Age in Guatemala 2009 to 2010: Prevalence and Predicted Neural Tube Defects Risk.” Birth Defects Research. Part A, Clinical and Molecular Teratology 106, no. 7: 587–595. 10.1002/bdra.23499. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Sayed AR, Bourne D, Pattinson R, Nixon J, and Henderson B. 2008. “Decline in the Prevalence of Neural Tube Defects Following Folic Acid Fortification and Its Cost-Benefit in South Africa.” Birth Defects Research. Part A, Clinical and Molecular Teratology 82, no. 4: 211–216. 10.1002/bdra.20442. [DOI] [PubMed] [Google Scholar]
  52. Sharma JB, and Gulati N. 1992. “Potential Relationship Between Dengue Fever and Neural Tube Defects in a Northern District of India.” International Journal of Gynaecology and Obstetrics 39, no. 4: 291–295. 10.1016/0020-7292(92)90260-p. [DOI] [PubMed] [Google Scholar]
  53. Singh S, Geddam JJB, Reddy GB, et al. 2017. “Folate, Vitamin B12, Ferritin and Haemoglobin Levels Among Women of Childbearing Age From a Rural District in South India.” BMC Nutrition 3, no. 1: 50. 10.1186/s40795-017-0173-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Sivaprasad M, Shalini T, Balakrishna N, et al. 2016. “Status of Vitamin B12 and Folate Among the Urban Adult Population in South India.” Annals of Nutrition & Metabolism 68, no. 2: 94–102. 10.1159/000442677. [DOI] [PubMed] [Google Scholar]
  55. Smithells RW, Sheppard S, and Schorah CJ. 1976. “Vitamin Deficiencies and Neural Tube Defects.” Archives of Disease in Childhood 51, no. 12: 944–950. 10.1136/adc.51.12.944. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Soofi S, Khan GN, Sadiq K, et al. 2017. “Prevalence and Possible Factors Associated With Anaemia, and Vitamin B (12) and Folate Deficiencies in Women of Reproductive Age in Pakistan: Analysis of National-Level Secondary Survey Data.” BMJ Open 7, no. 12: e018007. 10.1136/bmjopen-2017-018007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Subramanian M, Malhotra S, Kant S, Goswami K, Perumal V, and Kaloiya G. 2022. “Prevalence of Anemia Among Adolescent Girls Residing in Rural Haryana: A Community-Based Cross-Sectional Study.” Cureus 14, no. 1: e21091. 10.7759/cureus.21091. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Taksande A, Vilhekar K, Chaturvedi P, and Jain M. 2010. “Congenital Malformations at Birth in Central India: A Rural Medical College Hospital Based Data.” Indian Journal of Human Genetics 16, no. 3: 159–163. 10.4103/0971-6866.73412. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Tinker SC, Hamner HC, Qi YP, and Crider KS. 2015. “U.S. Women of Childbearing Age Who Are at Possible Increased Risk of a Neural Tube Defect-Affected Pregnancy Due to Suboptimal Red Blood Cell Folate Concentrations, National Health and Nutrition Examination Survey 2007 to 2012.” Birth Defects Research. Part A, Clinical and Molecular Teratology 103, no. 6: 517–526. 10.1002/bdra.23378. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. University of Otago, Ministry of Health. 2011. “A Focus on Nutrition: Key Findings of the 2008/09 New Zealand Adult Nutrition Survey.” https://www.health.govt.nz/system/files/documents/publications/a-focus-on-nutrition-v2.pdf.
  61. Wang A, Rose CE, Qi YP, Williams JL, Pfeiffer CM, and Crider KS. 2021. “Impact of Voluntary Folic Acid Fortification of Corn Masa Flour on RBC Folate Concentrations in the U.S. (NHANES 2011-2018).” Nutrients 13, no. 4: 1325. 10.3390/nu13041325. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Williams LJ, Mai CT, Edmonds LD, et al. 2002. “Prevalence of Spina Bifida and Anencephaly During the Transition to Mandatory Folic Acid Fortification in the United States.” Teratology 66, no. 1: 33–39. 10.1002/tera.10060. [DOI] [PubMed] [Google Scholar]
  63. World Health Organization. 2015a. “Guideline: Optimal Serum and Red Blood Cell Folate Concentrations in Women of Reproductive Age for Prevention of Neural Tube Defects.” https://iris.who.int/bitstream/handle/10665/161988/9789241549042_eng.pdf?sequence=1. [PubMed]
  64. World Health Organization. 2015b. “Serum and Red Blood Cell Folate Concentrations for Assessing Folate Status in Populations.” http://www.jstor.org/stable/resrep44521.
  65. Yadav S, Thakur M, and Kiranmala N. 2018. “Micronutrient Deficiency and Burden of Anaemia: A Population-Based Study From Haryana, India.” Journal of Clinical and Diagnostic Research 7, no. 4: QO01–QO05. 10.7860/NJLM/2018/36190:2315. [DOI] [Google Scholar]
  66. Yajnik CS, Deshpande SS, Jackson AA, et al. 2008. “Vitamin B12 and Folate Concentrations During Pregnancy and Insulin Resistance in the Offspring: The Pune Maternal Nutrition Study.” Diabetologia 51, no. 1: 29–38. 10.1007/s00125-007-0793-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  67. Zaganjor I, Sekkarie A, Tsang BL, et al. 2016. “Describing the Prevalence of Neural Tube Defects Worldwide: A Systematic Literature Review.” PLoS One 11, no. 4: e0151586. 10.1371/journal.pone.0151586. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

SUP - Das - Folate and Vitamin B12 Status in Women of Reproductive Age in Rural Haryana India

Data Availability Statement

Research data are not shared.

RESOURCES